Quick Answer
Rallybio Corp reported Common Stock Shares Outstanding of 5.28 million shares for the year ending 2025.
- Rallybio Corp showed an increase of +1.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Rallybio Corp's annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: 5.70 million shares | Q3 2021: 32.13 million shares | Q1 2022: 32.13 million shares | Q2 2022: 32.13 million shares | Q3 2022: 32.09 million shares | Q1 2023: 37.75 million shares | Q2 2023: 37.79 million shares | Q3 2023: 37.80 million shares | Q1 2024: 37.81 million shares | Q2 2024: 41.49 million shares | Q3 2024: 41.49 million shares | Q1 2025: 41.61 million shares | Q2 2025: 41.71 million shares | Q3 2025: 41.94 million shares.
- Over the full 6 years of available data (2020 to 2025), Rallybio Corp's Common Stock Shares Outstanding has declined by 77.4%.
- Historical annual values: Fiscal year 2025: 5.28 million shares | Fiscal year 2024: 5.19 million shares | Fiscal year 2023: 37.83 million shares | Fiscal year 2022: 37.84 million shares | Fiscal year 2021: 32.13 million shares | Fiscal year 2020: 23.41 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: